BEAM vs EDIT
BEAM 与 EDIT 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | BEAMBeam Therapeutics Inc. | EDITEDITAS MEDICINE, INC. |
|---|---|---|
| 市值 | $2.55B | $416.97M |
| 市净率 | 2.39 | — |
| 市销率 | 18.2x | 10.3x |
| 营收 | $156.03M(TTM) | — |
| 营收同比增长 | 120.0% | 25.4% |
| 净利润 | -$86.52M(TTM) | — |
| 净利同比增长 | 78.8% | 32.5% |
| 每股收益(稀释) | $-0.69(TTM) | — |
| 息税前利润率 | -274.6% | -394.9% |
| 净资产收益率 | -7.5% | -152.0% |
| 投入资本回报率 | -40.5% | — |
| 一年总回报 | +9.7% | -0.4% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:BEAM vs EDIT
| 指标 | BEAM | EDIT |
|---|---|---|
| 期末价值 | $13.2K | $970 |
| 总回报 | +31.6% | -90.3% |
| 年化收益 (CAGR) | +4.2% | -29.7% |
| 波动率 | 79.8% | 92.3% |
| 夏普比率 | 0.39 | 0.01 |
| 索提诺比率 | 0.61 | 0.02 |
| 最大回撤 | -89.1% | -98.9% |
基于 1662 个共同交易日,2020-02-06 → 2026-09-17 · 无风险利率 4.12%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)